Bristol-Myers Squibb has launched abatacept [Orencia] in the UK for moderate to severe rheumatoid arthritis

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 23-23(1)

Publisher: Adis International

Keywords: Abatacept, therapeutic use; Development-status; Product-launches; Rheumatoid-arthritis, treatment

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers